Gilead Sciences's most recent trend suggests a bullish bias. One trading opportunity on Gilead Sciences is a Bull Put Spread using a strike $108.00 short put and a strike $103.00 long put offers a potential 35.5% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $108.00 by expiration. The full premium credit of $1.31 would be kept by the premium seller. The risk of $3.69 would be incurred if the stock dropped below the $103.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Gilead Sciences is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Gilead Sciences is bullish.
The RSI indicator is above 80 which suggests that the stock is in overbought territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 9.6%
Thu, 04 Sep 2014 10:48:29 GMT
New Managers Revive Thrivent Large Cap Growth Fund
Wed, 03 Sep 2014 22:28:00 GMT
The Market's Roses, Thorns, and All Time Highs…
Wed, 03 Sep 2014 21:41:07 GMT
Gilead Sciences to Present at Two Upcoming Investor Conferences in September
Wed, 03 Sep 2014 21:00:00 GMT
Business Wire – Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from two upcoming investor conferences: the Robert W. Baird & Co. 2014 Heal
Infinity Pharma Joins AbbVie On Blood Cancer Drug
Wed, 03 Sep 2014 17:20:00 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook